Speakers

Dr Joachim Ermer

Dr Joachim Ermer

Ermer Quality Consulting

All times mentioned are CEST.

Objectives

Besides regulatory and compendial expectations, as discussed in the just published draft of a new USP General Information Chapter <1221> “Ongoing Procedure Performance Verification” this Live Online Training provides practical recommendations and orientation for demonstration of the continual suitability of analytical procedures across the analytical procedure lifecycle. In particular, efficient approaches will be presented to extract information and data from routine analysis. This will be illustrated with examples from quality control of chemical drug substances and biopharmaceuticals.

A comprehensive understanding of the real analytical performance is extremely helpful to identify, investigate and evaluate suspect (out-of-trend, OOT) or out-of specification (OOS) results as well as for a continuous process validation.

Background

According to the FDA-Guidance “Analytical Procedures and Methods Validation for Drugs and Biologics“ (2015), it should be continually assured that an analytical procedure remains fit for its intended purpose throughout its application. This includes an ongoing program for routine monitoring of analytical performance data, and the systematic evaluation of changes with the objective to evaluate regularly the need for optimization and revalidation, if needed. These activities belong to stage 3 of the analytical lifecycle management as discussed in the USP General Information Chapter <1220>. The ongoing performance verification is also discussed in the ICH Guideline Q14 “Analytical Procedure Development” (2023), and in the just published ICH Training Materials (Module 4 and 5).

Target Group

This training is aimed at executives and employees from Quality Control, Quality Assurance, and production who want to gain a better understanding of the GMP requirements as well as current discussions with respect to the lifecycle management of analytical procedures and are interested in practical recommendations for an efficient design, execution, and evaluation of a continuous analytical performance verification.

Date & Technical Requirements

Date of the Live Online Training
Monday, 29 September 2025, 14.00 h - 17.00 h CEST

Technical Requirements
We use Webex for our live online training courses and webinars. At www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.

Programme

Continuous/Ongoing Verification in Pharmaceutical Analysis - Live Online Training

Seminar Programme as PDF

Regulatory Requirements and the Lifecycle Concept of Analytical Procedures
  • FDA validation guidance (2015)
  • USP General information chapter <1220>
    - Stage 1: Procedure Design and Development
    - Stage 2: Procedure Performance Qualification
    - Stage 3: Ongoing Procedure Performance Verification
  • ICH Q14 “Analytical procedure development”
  • Draft USP General Information Chapter <1221> “Ongoing Procedure Performance Verification”
Workshop
Sources of data and information on analytical Performance

Evaluation of Procedure Performance
  • Risk management: Factors related to analytical procedure criticality & risk-based performance monitoring plans
  • Analytical Procedure Performance Metrics (conformity, validity, analytical control parameters)
  • Risk-based identification of suitable performance parameters (SST, from sample analysis, control samples)
  • Links to Analytical Procedure Control Strategy (ICH Q14, Training Module 4)
  • Continued verification of ATP requirements and periodic analytical performance assessment
  • Continual improvements
Monitoring and Trend Analysis
  • Control charts (Shewhart, range, standard deviation, CUSUM)
  • Statistical out-of-control rules
  • Pragmatic establishment of trending rules and limits (statistical, empirical)
  • Examples

ECA-Member*: € 590,-
Regular Fee*: € 690,-
EU/GMP Inspectorates*: € 590,-
APIC Member Discount*: € 640,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Additional dates on-site
Additional dates on-site
not available
icon
Additional dates online
Additional dates online
not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025